Holmed Group is an integrated service provider in the medical and pharmaceutical fields. Founded in 2019 and headquartered in Lebanon, it aspires to be a global player in the healthcare industry with a focus on the EMEA region. As the healthcare arm of Holcom Group, Holmed Group represents top-tier pharmaceutical companies including GlaxoSmithKline, Abbott, MSD, Sanofi, Janssen, Aspen, Baxter, Hikma, and Eisai in Lebanon, offering regulatory, market access, and distribution services.
Moreover, Holmed Group spearheads heart failure in Lebanon by representing Abbott Vascular and Abbott Structural Heart. The company also provides medical promotion services for pharmaceutical and medical companies throughout the Middle East as part of third-party promotion agreements with their Principals.
In terms of its values, Holmed Group is committed to equal employment opportunities and affirmative action, ensuring that employment decisions are based on job-related reasons regardless of an individual's background. The company highlights its dedication to diversity and inclusion by providing opportunities to all job applicants and employees.
With its strong presence in the healthcare and pharmaceutical industries, Holmed Group presents an intriguing investment opportunity for venture capitalists seeking to tap into the evolving healthcare landscape in the EMEA region.
For more information, please visit their website: [Holmed Group](website URL)